| 2023-03-02 | Sale | Atara Biotherapeutics, Inc. ATRA | EVP, Head of R&D | 5,074 0.005% | $3.63 | $18,403 | -56.42% | |
| 2022-11-16 | Sale | Atara Biotherapeutics, Inc. ATRA | EVP, Head of R&D | 4,342 0.0041% | $4.49 | $19,497 | -51.86% | |
| 2022-08-16 | Sale | Atara Biotherapeutics, Inc. ATRA | EVP, Head of R&D | 4,124 0.0041% | $5.03 | $20,760 | -30.97% | |
| 2022-05-17 | Sale | Atara Biotherapeutics, Inc. ATRA | EVP, Head of R&D | 3,873 0.0036% | $5.32 | $20,597 | -27.55% | |
| 2022-03-01 | Sale | Atara Biotherapeutics, Inc. ATRA | EVP, Head of R&D | 2,221 0.0021% | $9.86 | $21,890 | -53.97% | |
| 2022-02-10 | Sale | Atara Biotherapeutics, Inc. ATRA | EVP, Head of R&D | 5,000 0.0053% | $16.00 | $80,000 | -67.95% | |
| 2022-01-03 | Sale | Atara Biotherapeutics, Inc. ATRA | EVP, Head of R&D | 5,000 0.0047% | $16.01 | $80,050 | -69.98% | |
| 2021-12-01 | Sale | Atara Biotherapeutics, Inc. ATRA | EVP, Head of R&D | 5,000 0.0053% | $17.94 | $89,689 | -66.71% | |
| 2021-11-16 | Sale | Atara Biotherapeutics, Inc. ATRA | EVP, Head of R&D | 2,199 0.0022% | $17.12 | $37,640 | -60.79% | |
| 2021-11-02 | Sale | Atara Biotherapeutics, Inc. ATRA | EVP, Head of R&D | 5,000 0.0049% | $16.41 | $82,050 | -57.55% | |
| 2021-08-17 | Sale | Atara Biotherapeutics, Inc. ATRA | EVP, Head of R&D | 2,152 0.0023% | $12.53 | $26,969 | +4.18% | |
| 2021-05-18 | Sale | Atara Biotherapeutics, Inc. ATRA | EVP, Head of R&D | 5,184 0.0056% | $14.55 | $75,427 | +0.55% | |
| 2019-12-30 | Sale | Gossamer Bio, Inc. GOSS | Chief Medical Officer | 80,000 0.0714% | $7.50 | $600,004 | -17.39% | |
| 2019-12-27 | Sale | Gossamer Bio, Inc. GOSS | Chief Medical Officer | 3,988 0.0037% | $7.91 | $31,534 | -18.54% |